Suven Life Sciences Ltd

Suven Life Sciences is engaged in providing building blocks (bulk actives, drug intermediates and speciality chemicals) for global life science companies.

  • Market Cap: 486.86 Cr.
  • Current Price: 38.25
  • 52 weeks High / Low 67.50 / 15.04
  • Book Value: 30.45
  • Stock P/E: 12.52
  • Dividend Yield: 3.92 %
  • ROCE: 21.18 %
  • ROE: 14.61 %
  • Sales Growth (3Yrs): 9.93 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 1.00
Edit ratios
Pros:
Company has reduced debt.
Company is virtually debt free.
Stock is providing a good dividend yield of 3.92%.
Cons:
The company has delivered a poor growth of 5.39% over past five years.
Debtor days have increased from 49.78 to 82.62 days.

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
141.02 106.86 163.66 213.72 191.66 89.52 2.11 2.38 198.99 1.39 2.77 8.66
95.73 61.86 112.27 122.49 133.43 65.11 15.79 20.53 108.96 13.90 12.13 10.74
Operating Profit 45.29 45.00 51.39 91.23 58.23 24.41 -13.68 -18.15 90.03 -12.51 -9.36 -2.08
OPM % 32.12% 42.11% 31.40% 42.69% 30.38% 27.27% -648.34% -762.61% 45.24% -900.00% -337.91% -24.02%
Other Income 5.62 5.13 3.29 9.23 8.13 6.59 6.74 5.79 3.01 2.38 5.86 3.00
Interest 1.27 0.94 1.15 1.25 1.07 0.59 0.00 0.29 1.31 0.10 0.10 0.23
Depreciation 5.19 5.34 5.42 5.36 5.51 5.56 0.99 0.80 5.55 1.42 0.86 1.05
Profit before tax 44.45 43.85 48.11 93.85 59.78 24.85 -7.93 -13.45 86.18 -11.65 -4.46 -0.36
Tax % 33.48% 27.59% 28.10% 33.39% 35.03% 27.53% -4.92% 30.33% 33.66% 3.52% -0.90% -611.11%
Net Profit 29.57 31.75 34.60 62.51 38.84 18.01 -8.32 -9.38 57.18 -11.23 -4.50 -2.56
EPS in Rs 2.32 2.49 2.72 4.91 3.05 1.41 -0.65 -0.74 4.49 -0.88 -0.35 -0.20
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
117 140 129 150 204 258 510 521 499 543 625 663 212
105 122 116 137 181 205 291 361 369 378 392 440 146
Operating Profit 13 17 13 14 23 53 219 159 130 165 233 224 66
OPM % 11% 12% 10% 9% 11% 21% 43% 31% 26% 30% 37% 34% 31%
Other Income 3 -1 0 1 2 1 3 9 19 21 23 24 14
Interest 5 7 5 6 10 14 11 5 6 6 5 4 2
Depreciation 4 5 5 5 6 8 9 12 18 21 21 22 9
Profit before tax 6 5 4 3 9 33 203 152 126 159 230 222 70
Tax % -32% -40% -89% -219% -57% 6% 29% 28% 20% 23% 31% 32%
Net Profit 8 7 7 10 14 31 144 109 100 123 158 150 39
EPS in Rs 0.68 0.57 0.56 0.85 1.18 2.64 12.34 8.54 7.86 9.70 12.45 11.79 3.06
Dividend Payout % 35% 41% 41% 28% 24% 11% 20% 7% 25% 10% 12% 13%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:16.84%
5 Years:5.39%
3 Years:9.93%
TTM:-25.86%
Compounded Profit Growth
10 Years:26.98%
5 Years:-1.18%
3 Years:15.85%
TTM:-0.66%
Stock Price CAGR
10 Years:33.80%
5 Years:16.22%
3 Years:47.58%
1 Year:131.68%
Return on Equity
10 Years:19.21%
5 Years:17.18%
3 Years:16.20%
Last Year:14.61%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
12 12 12 12 12 12 12 13 13 13 13 13 13
Reserves 101 103 106 115 116 143 253 547 611 719 854 981 375
Borrowings 55 43 50 66 98 117 91 109 83 71 34 38 5
38 29 37 31 60 56 132 105 68 74 114 143 17
Total Liabilities 204 186 205 224 285 328 487 773 774 876 1,014 1,175 410
110 112 110 106 132 162 179 172 305 306 308 293 25
CWIP 4 4 3 3 24 4 13 107 7 10 25 111 0
Investments 8 6 12 20 5 0 0 0 23 366 381 366 242
83 64 80 94 124 162 295 494 438 195 301 404 143
Total Assets 204 186 205 224 285 328 487 773 774 876 1,014 1,175 410

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
4 34 13 5 34 31 121 143 90 147 105 76
-16 -15 -10 -12 -32 -15 -36 -110 -62 -353 -38 -62
6 -21 -2 8 -2 3 -38 179 -68 -30 -52 -23
Net Cash Flow -7 -2 1 1 -0 19 47 212 -40 -236 15 -8

Ratios Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 7% 11% 5% 5% 9% 19% 68% 31% 17% 19% 25% 21%
Debtor Days 110 56 92 76 45 34 47 28 39 31 36 83
Inventory Turnover 2.22 2.22 1.63 2.06 2.25 2.09 2.45 2.60 2.37 2.08 1.63 1.42

Shareholding pattern in percentages

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00
2.16 2.06 2.11 2.50 4.41 5.83 6.07 5.67 4.71 4.02 4.29 3.95
5.79 5.86 5.56 4.85 2.28 2.08 2.41 2.48 3.10 3.39 3.73 0.86
32.04 32.08 32.33 32.65 33.31 32.09 31.52 31.85 32.19 32.59 31.98 35.19